BioCentury
ARTICLE | Company News

Oval Medical deal

May 21, 2012 7:00 AM UTC

An undisclosed pharma and Oval partnered to evaluate combining the pharma's drug with Oval's autoinjector technology. The pharma will have the option to jointly develop and commercialize an autoinject...